Clinical data | |
---|---|
Trade names | Cydectin, Equest, ProHeart, Quest.[1] |
Other names | CL 301,423;[2] milbemycin B.[2] |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth, topical, subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.163.046 |
Chemical and physical data | |
Formula | C37H53NO8 |
Molar mass | 639.830 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Moxidectin is an anthelmintic drug used in animals to prevent or control parasitic worms (helminths), such as heartworm and intestinal worms, in dogs, cats, horses, cattle, sheep and wombats.[4] Moxidectin kills some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells; when moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite.
Awasthi 2013
was invoked but never defined (see the help page).